Hottest Stocks (Over $10)	Hottest Stocks ($2-$10)	Biggest Losers (Over $10)	Biggest Losers ($2-$10)	Hottest Industries	Hottest Sectors	EPS / Sales Surprises
Enter Ticker Symbol:   Ticker Lookup Company Quote Company Profile Research Summary EPS Consensus Perspective Insider Transactions Price Performance

Enter any portion of the company’s name to find its corresponding ticker symbol:

Search for :

Zacks Company Profile for Surrozen, Inc. (SRZN : NSDQ)

• Company Description    Surrozen Inc. is a company pioneering targeted therapeutics which selectively activates the Wnt pathway for tissue repair and regeneration. Surrozen Inc., formerly known as Consonance-HFW Acquisition Corp., is based in SOUTH SAN FRANCISCO, Calif. Number of Employees: 44

• Price / Volume Information    Yesterday's Closing Price: $25.48 Daily Weekly Monthly 20 Day Moving Average: 652,876 shares Shares Outstanding: 11.61 (millions) Market Capitalization: $295.82 (millions) Beta: 0.47 52 Week High: $37.83 52 Week Low: $11.39 Short Interest Ratio:   % Price Change % Price Change Relative to S&P 500 4 Week -24.35% -23.55% 12 Week 22.32% 19.34% Year To Date 12.74% 1.78%

• Address & Contact Information Street Address Phone / Fax Email Address Web URL 171 Oyster Point Blvd Suite 400 - South San Francisco,CA 94080 USA ph: 650-489-9000 fax: - investorinfo@surrozen.com http://www.surrozen.com

• General Corporate Information    Officers Craig Parker - President and Chief Executive Officer and Director David J. Woodhouse - Chair of the Board of Directors Andrew Maleki - Chief Financial Officer Anna Berkenblit - Director Christopher Chai - Director Peer Information Surrozen, Inc. (GSAC) Surrozen, Inc. (CASIF) Surrozen, Inc. (ALCD.) Surrozen, Inc. (OMNN) Surrozen, Inc. (CGPI.) Surrozen, Inc. (CATX) Industry / Sector / Ticker Info Analyst Coverage: No Industry Group: MED-DRUGS Sector: Medical CUSIP: 86889P208 SIC: 2836 Fiscal Year Fiscal Year End: December Last Reported Quarter: 06/01/26 Next Expected EPS Date: 11/06/26 Share - Related Items Shares Outstanding: 11.61 Most Recent Split Date: 12.00 (0.07:1) Beta: 0.47 Market Capitalization: $295.82 (millions)

• EPS Information     • Dividend Information Analyst Coverage: No Dividend Yield: 0.00% Current Fiscal Quarter EPS Consensus Estimate: $-1.07 Indicated Annual Dividend: $0.00 Current Fiscal Year EPS Consensus Estimate: $-1.01 Payout Ratio: Number of Estimates in the Fiscal Year Consensus: 1.00 Change In Payout Ratio: Estmated Long-Term EPS Growth Rate: % Last Dividend Paid: NA - $0.00 Next EPS Report Date: 11/06/26

• Fundamental Ratios P/E Current FY Estimate: - Trailing 12 Months: - PEG Ratio: - Price Ratios Price/Book: - Price/Cash Flow: - Price / Sales: 25.70 EPS Growth vs. Year Ago Period: 64.04% vs. Previous Quarter: 91.14% Sales Growth vs. Year Ago Period: 408.65% vs. Previous Quarter: 0.00% ROE 09/30/26 - - 06/30/26 - - 03/31/26 - - ROA 09/30/26 - - 06/30/26 - -93.62 03/31/26 - -154.08 Current Ratio 09/30/26 - - 06/30/26 - 12.14 03/31/26 - 11.91 Quick Ratio 09/30/26 - - 06/30/26 - 12.14 03/31/26 - 11.91 Operating Margin 09/30/26 - - 06/30/26 - -872.44 03/31/26 - -2,139.26 Net Margin 09/30/26 - - 06/30/26 - -2,885.33 03/31/26 - -4,810.50 Pre-Tax Margin 09/30/26 - - 06/30/26 - -2,885.33 03/31/26 - -4,571.14 Book Value 09/30/26 - - 06/30/26 - -18.83 03/31/26 - -24.21 Inventory Turnover 09/30/26 - - 06/30/26 - - 03/31/26 - - Debt-to-Equity 09/30/26 - - 06/30/26 - - 03/31/26 - - Debt-to-Capital 09/30/26 - - 06/30/26 - - 03/31/26 - -

Powered by Zacks Investment Research ©